Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses. (Q48002526)

7 February 2018

title

Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses. (English)

1 reference

7 February 2018

author

Christian Brander

3

1 reference

7 February 2018

Bruce D. Walker

12

Bruce D Walker

1 reference

7 February 2018

Marcus Altfeld

2

Marcus Altfeld

1 reference

7 February 2018

Alicja Piechocka-Trocha

9

Alicja Trocha

1 reference

7 February 2018

Marylyn Addo

10

Marylyn M Addo

1 reference

7 February 2018

Philip J. R. Goulder

11

Philip J R Goulder

1 reference

7 February 2018

Nesli Basgoz

4

Nesli Basgoz

1 reference

7 February 2018

Spyros A Kalams

8

Spyros A Kalams

1 reference

7 February 2018

Rika Draenert

1

Rika Draenert

1 reference

7 February 2018

Alysse G Wurcel

6

Alysse G Wurcel

1 reference

7 February 2018

author name string

Colleen Corcoran

5

1 reference

7 February 2018

David R Stone

7

1 reference

7 February 2018

publication date

1 April 2003

1 reference

7 February 2018

Journal of Immunological Methods

published in

1 reference

7 February 2018

volume

275

1 reference

7 February 2018

page(s)

19-29

1 reference

7 February 2018

issue

1-2

1 reference

7 February 2018

The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900541-0

A decaepitope polypeptide primes for multiple CD8+ IFN-gamma and Th lymphocyte responses: evaluation of multiepitope polypeptides as a mode for vaccine delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900541-0

Identification of dominant optimal HLA-B60- and HLA-B61-restricted cytotoxic T-lymphocyte (CTL) epitopes: rapid characterization of CTL responses by enzyme-linked immunospot assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900541-0

Vpr Is Preferentially Targeted by CTL During HIV-1 Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900541-0

Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900541-0

Definition of an optimal cytotoxic T lymphocyte epitope in the latently expressed Kaposi's sarcoma-associated herpesvirus kaposin protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900541-0

Vaccine-induced immune responses in rodents and nonhuman primates by use of a humanized human immunodeficiency virus type 1 pol gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900541-0

DNA vaccination of macaques with several different Nef sequences induces multispecific T cell responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900541-0

A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900541-0

Weak anti-HIV CD8(+) T-cell effector activity in HIV primary infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900541-0

Dynamics of CD4 and CD8 T cell responses to cytomegalovirus in healthy human donors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900541-0

Magnitude of functional CD8+ T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900541-0

Definition of five new simian immunodeficiency virus cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I molecules: evidence for an influence on disease progression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900541-0

CD8 CTL responses in vaccines: emerging patterns of HLA restriction and epitope recognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900541-0

Diversity considerations in HIV-1 vaccine selection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900541-0

Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900541-0

Comprehensive Analysis of CD8+-T-Cell Responses against Hepatitis C Virus Reveals Multiple Unpredicted Specificities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900541-0

Use of overlapping peptide mixtures as antigens for cytokine flow cytometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900541-0

Identification and prevalence of CD8(+) T-cell responses directed against Epstein-Barr virus-encoded latent membrane protein 1 and latent membrane protein 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900541-0

Identification of known and novel immunogenic T-cell epitopes from tumor antigens recognized by peripheral blood T cells from patients responding to IL-2-based treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900541-0

Immune defence against HIV-1 infection in HIV-1-exposed seronegative persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900541-0

Evaluation of the interferon-gamma ELISPOT-assay for quantification of peptide specific T lymphocytes from peripheral blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900541-0

Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2802%2900541-0

10.1016/S0022-1759(02)00541-0

7 January 2021

Identifiers

DOI

1 reference

7 February 2018

release_73c3nlcklrhm7p4hhqo42kwope

Fatcat ID

0 references

PubMed ID

12667667

1 reference

7 February 2018